Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Messas

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Journal De Medecine Vasculaire|February 15, 2020
Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)H Rafii, C Frère, I Benzidia, et al.
British Journal of Haematology|November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational studyF Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Journal De Medecine Vasculaire|February 15, 2020
Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)H Rafii, C Frère, I Benzidia, et al.
British Journal of Haematology|November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational studyF Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
Pageof 4